Automation for blood fractionation: Quicker, more efficient, and saferThe demand for blood plasma and other blood products is constantly increasing, but the raw material blood is becoming increasingly scarce. Therefore, efficiency, quality, and performance are important issues in blood fractionation.utomation for blood fractionation: Quicker, more efficient, and saferThe demand for blood plasma and other blood products is constantly increasing, but the raw material blood is becoming increasingly scarce. Therefore, efficiency, quality, and performance are important issues in blood fractionation.
It is not covered by most Medicare and insurance plans, but manufacturer and pharmacy coupons can help offset the cost. The lowest GoodRx price for the most common version of Basaglar is around $331.94, 15% off the average retail price of $392.68.
Basaglar is the first insulin product approved through an abbreviated approval pathway under the Federal Food, Drug, and Cosmetic Act. A 505(b)(2) application was submitted for Basaglar that relied, in part, on the FDAâs finding of safety and effectiveness for Lantus (insulin glargine injection) to support approval.